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Summary.-The incidence of mammary tumours developing after administration of
the carcinogen DMBA (at 50 days of age) has been determined in 2 strains of
Sprague-Dawley rat. Untreated animals of each strain were exsanguinated in
dioestrus at a time corresponding to the early post-carcinogen stage (at 70 days of
age) and the plasma concentrations of prolactin, oestradiol-17B and progesterone
were measured byradioimmunoassay. In aninbred strain ofrats, tumour-induction
rate was 6.4% and plasma prolactin concentration was2-5 x lower than that found in
a random-bred strain with a tumour-induction rate of 41.6%. No difference was
found between the 2 strains in the level of either ovarian hormone. It is concluded
that the difference between these strains in mammary gland susceptibility to DMBA
may be related to plasma prolactin concentration, but it is unlikely to be determined
by the ovarian hormones.
In the rodent, mammary tumours can
be readily induced following the admini-
stration of 7,12-dimethyl benz(a)-
anthracene or " DMBA " (Huggins, Grand
and Brillantes, 1961) and the sensitivity
of the mammary gland to the carcinogen
is dependent upon the prevailing endocrine
status. In particular, prolactin (Meites,
1972) and ovarian hormones (Geyer et al.,
1953; Huggins, Briziarelli and Sutton,
1959; Jabara and Harcourt, 1970) have
been reported to alter the sensitivity of
their target organ, the mammary gland,
to tumorigenesis.
In a previous study from this labora-
tory (Boyns et al., 1973), it has been shown
that in 2 different strains of Sprague-
Dawley rat, the rate of tumour induction
was much higher in the strain with the
higher concentration of plasma prolactin
at dioestrus. In view of uncertainty as
to whetherprolactin oranovarianhormone
has a dominant role in determining the
rates of growth and induction of these
tumours, we have repeated and extended
this work to include assessment of the
ovarian hormones, as well as of prolactin,
in relation to tumour incidence.
MATERIALS AND METHODS
Animals.-The random-bred strain ofrats
(OLAC) was originally purchased from Oxford
Laboratories. Fresh stock animals have
recently been introduced into this strain from
Oxford and this appears to have restored
sensitivity to tumour induction, which was
diminishing with time, to former high levels.
The inbred strain of rats (ADRA) was
originally purchased from the Animal Dis-
eases Research Association, Edinburgh.
Tumour induction.-Two groups of rats
(101 OLAC and 62 ADRA) were each treated
by the intragastric administration of 30 mg
DMBA, at 50-55 days of age. At this age,
the inbred rats (ADRA) had a body weight
significantly lower (by approximately 15%)
than that of the random-bred rats (OLAC),
and thus received a slightly higher dose of
DMBA/g body wt. Subsequently, animals
were palpated for tumours at regular intervals
until approximately 6 months of age.HORMONES AND INDUCED MAMMARY TUMOUR.S
Collection of blood from animals in di-
oestrus.-Vaginal smears were taken daily
from 13 OLAC rats and 12 ADRA animals,
at approximately 70 days of age. After at
least 2 oestrous cycles, rats were killed
between 11.30 and 12.03 h, in dioestrus, by
exsanguination through the abdominal aorta
under ether anaesthesia, the blood being
collected into a heparinized syringe. The
OLAC rats all exhibited regular 4-day cycles,
but the ADRA strain showed longer, irregular
cycles as judged from the vaginal smears,
with a tendency to show no obvious pro-
estrous smear, and a prolongation of the
oestrous phase. Accordingly, " dioestrus "
was defined for all rats as the third day of
sequence in which clear, characteristic smears
were seen as follows: Day 1: oestrus, Day 2:
metoestrus and Day 3: dioestrus (this there-
fore corresponded to the day before proestrus
in the OLAC rats, but such was not neces-
sarily the case in the ADRA animals).
Blood was stored on ice and the plasma was
separated within 30 min by centrifugation.
Determination ofplasma hormone levels.-
Plasma oestradiol-17B concentration was
measured by radioimmunoassay, as pre-
viously described, usinga single3-0-ml portion
of plasma (Hawkins et al., 1975). Assay
sensitivity for this volume of plasma was
0-16 ng/100 ml plasma.
Plasma prolactin concentration was
measured also by radioimmunoassay by the
method described previously, with minor
modifications (Hawkins et al., 1975). [1251]
iodo-prolactin was prepared by the method of
Redshaw and Lynch (1974) and the mean
assay sensitivity using such preparations was
3-3 ng RP-1/ml (n = 22 assays, range 1 to
7-6 ng/ml). Inevitable deterioration of pro-
lactin standard occurs on storage (NIAMD
instructions) and a correction has been made
for this using the quality control data, a
procedure which results in values lowei than
those previously reported by us.
Plasma progesterone concentration was
measured using duplicate 100-1l portions of
plasma by the method of Cameron and
Scarisbrick (1973). Assay sensitivity (de-
fined as the mass required to cause a 10% fall
from the maximum found for the standard
curve, corrected for losses on extraction) was
0-6 ng/ml plasma.
RESULTS
The rate of induction of mammary
tumours was much greater in the random-
bred strain of rats than in the inbred
ADRA strain (Table I). Although the
tumours were not all examined histo-
logically, in our experience the formation
of fibromata generally occurs much later
than 4 months after DMBA admini-
stration, and thus this difference almost
certainly reflects the difference in induc-
tion of adenocarcinomata.
TABLE I. Incidence ofMammary Tumour
Formation in 2 Strains of Rat
OLAC ADRA
Total no. treated 101 62
Died due to infections etc. 12 5
Number with tumours 42 4
Number without tumours 47 53
% Incidence 41-6 6-4
All rats received 30 mg DMBA intragastrically
at 50-55 days of age and were palpated at intervals
until approximately 6 months of age. All palpable
tumours > 0 5 cm in diameter were counted,
irrespective of histology. Incidence was calculated
as a percentage of all the rats treated.
TABLE II.-Plasma Hormone Levels in 2 Strains
ofSprague-Dawley Rat
Hormone
(plasma
concentration*
units)
Oestradiol- 17B
(ng/100 ml)
Progesterone
(ng/ml)
Prolactin
(ng RP-1/ml)
(no animals)
Assay
sensitivity
0-16
1- 1-01
0-6 20-7
± 9-4
3 3 10( 2
-4-11 4
(12)
* Values are means + s.d.
t Significantly different from the value in the ADRA strain by the Wilcoxon Rank test, P < 0-01.
Strain of rat
ADRA OLAC
1-51 1-45
4- 0-68
20 8
±11 3
26-3t
4-17 5
(13)
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Examination of the plasma hormone
concentration inthese 2 strainsofrat(Table
II) revealed no significant difference be-
tween the animals in the levels of circulat-
ing ovarian hormones, but demonstrated
the existence of a significant difference in
the levels of circulating plasma prolactin.
DISCUSSION
In an earlier study (Boyns et al., 1973),
it was found that in 3 strains of rat, the
differences in incidence of tumour induc-
tion by DMBA were apparently associated
with differences in circulating prolactin
concentration measured at 50 days of age,
the time of administration of the carcino-
gen. In the present work, the marked
difference in tumour induction rate be-
tween the 2 strains of Sprague-Dawley
rat has been confirmed, and measurement
of the plasma hormone concentrations at
70- days of age shows that the difference
in plasma prolactin levels between the
strains is maintained from 50 to 70 days.
This time would correspond to the early
post-carcinogen period in rats treated with
DMBA, and in view of the conclusion of
Brown and Shellabarger (1974) that dif-
ferences in tumour susceptibility to DMBA
are determined after carcinogen-cell inter-
action, it may well be the time at which
inter-strain differences are involved. In
contrast to the difference between strains
in plasma prolactin concentration at this
stage, we found no difference in the plasma
concentration of either of 2 major ovarian
hormones. A similar, apparent associ-
ation between increased incidence of
tumour induction and increased plasma
prolactin levels has been noted in rats fed
on a high fat diet (Chan, Didato and
Cohen, 1975) but in that study the ovarian
hormones were not examined.
The effects of prolactin and ovarian
hormones on the induction of mammary
tumours by carcinogens are complex.
The absence of either the pituitary gland
(Foulds, 1975) or the ovary (Dao, 1962;
Talwalker, Meites and Mizuno, 1964) has
been reported to inhibit tumour induction.
Thus both prolactin (Meites, 1972) and
oestrogen (Sinha and Dao, 1972) have
been implicated in tumorigenesis, though
tumours can be induced in ovariectomized
rats treated by administration ofprolactin
and growth hormone (Talwalker et al.,
1964). By contrast, high levels of either
prolactin (Meites, 1972; GalaandLoginsky,
1973) or oestrogen (Nagasawa et al., 1974)
may protect the mammary gland from
carcinogenesis.
In the 2 strains of rat studied here it
seems unlikely that the level of either of
the 2 major ovarian hormones normally
determines the susceptibility of the mam-
mary gland to carcinogenesis.
It should be noted, however, that in
the mouse, attempts to relate plasma,
pituitary or urinary levels of prolactin to
the incidence of spontaneous tumours in
2 different strains have led to the sugges-
tion that, for prolactin, mammary turn-
over rather than plasma level may
determine susceptibility to spontaneous
mammary tumorigenesis (Sinha, Selby and
Vanderlaan, 1974; Sinha et al., 1974).
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